Effects of antiapoptotic constructs and pharmacologic inhibitors on CD40L- and T-cell—mediated death of IκBαAA-transfected DCs
. | Prevention of death mediated by . | . | |
---|---|---|---|
. | CD40L . | T cells plus sAg . | |
Constructs* | |||
A1 | ++ | ++ | |
Bcl-2 | ++ | ++ | |
Bcl-xL | ++ | ++ | |
cFlip | + | + | |
IEX-1 | + | + | |
API1/HIAP2 | - | - | |
API2/HIAP1 | - | - | |
API3/XIAP | - | - | |
AP14/survivin | - | - | |
A20 | - | - | |
Gadd45β | - | ND | |
Pharmacologic inhibitors† | |||
Caspase-3 inh. | ++ | ND | |
Caspase-8 inh. | - | ND |
. | Prevention of death mediated by . | . | |
---|---|---|---|
. | CD40L . | T cells plus sAg . | |
Constructs* | |||
A1 | ++ | ++ | |
Bcl-2 | ++ | ++ | |
Bcl-xL | ++ | ++ | |
cFlip | + | + | |
IEX-1 | + | + | |
API1/HIAP2 | - | - | |
API2/HIAP1 | - | - | |
API3/XIAP | - | - | |
AP14/survivin | - | - | |
A20 | - | - | |
Gadd45β | - | ND | |
Pharmacologic inhibitors† | |||
Caspase-3 inh. | ++ | ND | |
Caspase-8 inh. | - | ND |
Modified DCs were cultured in the absence or in the presence of CD40L or autologous CD4+ T cells plus sAg, and viable DCs were counted 3 days later using FACS. Survival of control-transfected DCs and of IκBαAA-transfected DCs in the presence of CD40L or T cells was set to 100% and 0%, respectively. (++) Rescue of survival of 50% or more to 100%, (+) of 10% or more to 50%, and (-) of less than 10% in CD40L-exposed (left column) and T cell/sAg-exposed (right column) DCs. Results are representative of 2 to 4 independent experiments.
ND indicates not determined.
Indicated transgenes or empty vector only were cotransfected with IκBαAA or control vector.
Alternatively, IκBαAA- or control vector—transfected DCs were incubated with the indicated caspase inhibitors (20 μM each).